Biofrontera Inc
NASDAQ:BFRI 10:20:19 AM EDT
Other Pre-Announcement
Biofrontera Reports Q1 Revenue Rose 106%
Published: 05/13/2022 11:44 GMT
Biofrontera Inc (BFRI) - Reports First Quarter 2022 Financial Results and Provides a Business Update.
Q1 Revenue Rose 106 Percent to $9.8 Million.
Biofrontera - Cash and Cash Equivalents Were $22.4 Million As of March 31, 2022.
Biofrontera - Maintains Its Previously Announced Financial Guidance for 2022.
Biofrontera - Believes Its Cash and Cash Equivalents Are Sufficient to Fund Operations for at Least the Next 12 Months.
Biofrontera - Qtrly EPS $0.32.
Q1 Revenue Rose 106 Percent to $9.8 Million.
Biofrontera - Cash and Cash Equivalents Were $22.4 Million As of March 31, 2022.
Biofrontera - Maintains Its Previously Announced Financial Guidance for 2022.
Biofrontera - Believes Its Cash and Cash Equivalents Are Sufficient to Fund Operations for at Least the Next 12 Months.
Biofrontera - Qtrly EPS $0.32.